Vivimed Labs in the limelight

Vivimed Labs is in the limelight today morning. The stock which had closed yesterday at Rs.105.05, rose to an intra day high at Rs.113.90, going up 8%. Volumes are all good.

There is optimism on the counter as the USFDA has given zero 483 observations after inspecting the company's API manufacturing facility in Sant Celoni, Spain.

This was a routine inspection.

This comes as very good news, a cause for celebration as such “zero” observations do not occur so frequently. Thus FDA giving this nod is good news.